Delivery Order SPE2DB20D3103-SPE2DB24FM5X6

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,329.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of THROMBIN-JMI, a medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, with a ceiling value of $41,040.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 20,000 unit vials of Thrombin-JMI, a pharmaceutical product, with a performance period extending through May 9, 2025. This contract is not set-aside and is awarded as a firm-fixed-price contract. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract covers the delivery of 20,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, to support military healthcare programs. The award has a firm fixed price of $6,410.56 and a completion date of July 8, 2024. No set-aside designation was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,739.44 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a specialized blood coagulant product. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. The...
This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,470.00 firm fixed-price delivery order is for the supply of 20,000 unit vials of Thrombin-JMI, a medical product used in various healthcare applications. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS to the Defense Logistics Agency (DLA), a major defense agency responsible for logistics support to the U.S. military. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on September 22, 2023 with a ceiling value of $6,595.68 and a completion date of September 25, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation,...
This is a single federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of the pharmaceutical product Thrombin-JMI, with a ceiling value of $4,801.44 and a completion date of January 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,370.35 fixed-price delivery order is for the provision of 20,000 unit vials of Thrombin-JMI, a critical medical product used in surgical procedures. The contract has a period of performance through November 29, 2024 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 20,000 unit vials of THROMBIN-JMI, a specialty medication. The firm-fixed-price contract has a ceiling value of $26,403.22 and a period of performance through March 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FM5X6
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is for the delivery of THROMBIN-JMI 20,000 UNIT VIALS, a specialty pharmaceutical product. The contract, valued at $5,928.00, was awarded by the Defense Logistics Agency (DLA) as a delivery order with a firm fixed price. The contract has an ultimate completion date of February 8, 2024. There is no set-aside designation for this award.

Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:21 AM